Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai (KR)

National institute of Siddha

Status and phase: Completed; Phase 2

Conditions: Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied

Treatments: Drug: kandhaga rasayanam

Study type: Interventional

Funder types: Other

Identifiers

NCT02238912

EXII(1)/29097/2011

Details and patient eligibility

About

this study is intended to find out the therapeutic efficacy of the siddha drug Kandhaga Rasayanam in Padarthamarai ( Ring worm infection )

Enrollment: 50 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients clinically diagnosed with tinea infection.
• direct microscopy skin scraping test positive.

Exclusion criteria

• pregnant or nursing women.
• use of other topical or oral antifungals, immunosuppressive drugs, anthelmintic drugs either currently or during 2 weeks preceeding initiation of drug trial.
• allergy or hyperensitivity to any component of the drug.
• clinical case of eczema, lichen planus, pityriasis versicolor, drug induced eruptions, urticaria, intertrigo, tinea ungium.
• diabetic patients.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Kandhaga Rasayanam- single arm

Experimental group

Description:

Kandhaga Rasayanam- 2grams twice a day for 45 days

Treatment:

Drug: kandhaga rasayanam